DOI: https://doi.org/10.22141/2306-2436.7.4.2018.148361

Clinical and pharmacological, classification and legal, nomenclature and legal distribution of medicines for pharmacotherapy of depression among combatants (F 32-33)

V. V. Shapovalov, A. O. Gudzenko, V. O. Shapovalova, V. V. Shapovalov

Abstract


Background. Formation of mental disorders in the area of military conflict occurs in emergencies, which are fighting, leading to the emergence of stress disorders, and in the future after returning to normal living conditions can lead to decompensation of personality disorders, post-traumatic stress disorder, depression and suicide. The purpose was to conduct clinical and pharmacological, classification and legal, nomenclature and legal distribution of medicines for pharmacotherapy of depression among combatants with determination of parameters of their control regime. Materials and methods. The research used the current normative, legal and methodological documents, the State Register of Medicines of Ukraine, scientific sources, instructions for medical use of medicines, Internet resources. Used regulatory, documentary, forensic and pharmaceutical methods of analysis. Results. The article deals with the clinical and pharmacological, classification and legal, nomenclature and legal distribution of medicines with the determination of parameters of their control regime by ICD-10 codes F32-33 for the pharmacotherapy of depression among patients-combatants who receive medical care and pharmaceutical provision. Conclusions. Established that for pharmacotherapy of depression in healthcare establishments medicines prescribed, which: according to the clinical and pharmacological groups belong to the ATC codes "N04B", "N05A" and "N06A"; by classification and legal group – to the general group; by the nomenclature and legal group – to the prescription group. Determined that the circulation of antidepressant and antipsychotic medicines for the pharmacotherapy of depression among combatants in medical institutions carried out based on a license for medical practice, and in pharmacy establishments – based on a license for wholesale and retail trade of medicines. Implementation of the parameters of the control regime of medicines for pharmacotherapy of depression in the activity of healthcare facilities is relevant for psychiatrists, narcologists and general practitioners, and will ensure the proper organization of the order of their treatment at the stages of appointment, issue, storage, accounting, quality control and release in accordance with the requirements of the current legislation.


Keywords


pharmaceutical law; forensic pharmacy; depression; control regime; circulation; medicine, combatants

References


US department of the army. Combat and operational stress control manual for leaders and soldiers. Washington, DC: DA; 2009. Field Manual 6-22.5.

McCarroll J. E., Ursano R. J., Liu X. et al. Deployment and the probability of spousal aggression by US Army soldiers // Mil Med. 2000; 165: 41–44.

Охорона психічного здоров’я в умовах війни / пер. з англ. Т. Семигіна, І. Павленко, Є. Овсяннікова [та ін.]. К.: Наш формат, 2017. 1068 с.

Попелюшко Р. П. Результати дослідження психологічних особливостей комбатантів до та після участі у бойових діях [Електронний ресурс]. Innovative Solutions In Modern Science. 2017. №5 (14). URL: http://elar.khnu.km.ua/jspui/bitstream/123456789/5583/3/1239-4890-1-PB.pdf.

Денисенко М. М., Лакинський Р. В., Шестопалова Л. Ф., Лінський І. В. Основні клінічні варіанти постстресових розладів у комбатантів. Український вісник психоневрології. 2017. Т. 25, вип. 2 (91). С. 40-44.

Устінов О. В. Посттравматичний стресовий розлад: спеціалізована допомога [Електронний ресурс]. Український медичний часопис. 2016-03-04. URL: https://www.umj.com.ua/article/93804/posttravmatichnij-stresovij-rozlad-specializovana-dopomoga.

Стаціонарне лікування учасників АТО / МОЗ України, УкрНДІ соціальної і судової психіатрії та наркології. 2015. 28 с.

Concerning the importance of forensic and pharmaceutical researches to improve patients’ accessibility to medicines / V. Shapovalov (Jr.), А. Gudzenko, L. Komar, А. Butko, V. Shapovalova, V. Shapovalov // Pharmacia. 2017. Vol. 65, №2. P. 23–29. URL: http://bsphs.org/wp-content/uploads/2017/07/Shapovalov.pdf.

Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society [Electronic resource] / V. Shapovalov (jr.), S. Zbrozhek, A. Gudzenko, V. Shapovalova, V. Shapovalov. International Journal of Pharmaceutical Sciences Review and Research. 2018. 51 (1), July-August 2018; Article No. 18, P. 118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf.

Forensic and pharmaceutical analysis of addictive morbidity because of the use of narcotic psychoactive substances in Ukraine (retrospective aspect) [Electronic resource] / V. Shapovalov (jr.), A. Gudzneko, V. Shapovalova, V. Shapovalov. International Journal of Pharmaceutical Sciences and Research. 2018. Vol. 3; Is. 3; July 2018; P. 22-25. URL: http://www.pharmacyjournal.net/archives/2018/vol3/issue3.




Copyright (c) 2018 Health of Society

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2019